Search results for the GEO ID: GSE1413
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM23276
GPL339
AKT_RAD001_48hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23277
GPL339
AKT_RAD001_48hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23279
GPL339
AKT_RAD001_48hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23280
GPL339
AKT_RAD001_48hours_5 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23281
GPL339
AKT_PLACEBO_48hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23282
GPL339
AKT_PLACEBO_48hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23283
GPL339
AKT_PLACEBO_48hours_3 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23284
GPL339
AKT_PLACEBO_48hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23285
GPL339
AKT_PLACEBO_48hours_5 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23286
GPL339
AKT_RAD001_12hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23287
GPL339
AKT_RAD001_12hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23288
GPL339
AKT_RAD001_12hours_3 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23289
GPL339
AKT_RAD001_12hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23290
GPL339
AKT_RAD001_12hours_5 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23291
GPL339
AKT_PLACEBO_12hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23292
GPL339
AKT_PLACEBO_12hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23293
GPL339
AKT_PLACEBO_12hours_3 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23294
GPL339
AKT_PLACEBO_12hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23295
GPL339
AKT_PLACEBO_12hours_5 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 1
GSM23296
GPL339
WT_RAD001_48hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23297
GPL339
WT_PLACEBO_48hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23298
GPL339
WT_PLACEBO_48hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23299
GPL339
WT_PLACEBO_48hours_3 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23300
GPL339
WT_PLACEBO_48hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23301
GPL339
WT_RAD001_12hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23302
GPL339
WT_RAD001_12hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23303
GPL339
WT_RAD001_12hours_3 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23304
GPL339
WT_PLACEBO_12hours_1 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23305
GPL339
WT_PLACEBO_12hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23306
GPL339
WT_PLACEBO_12hours_3 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23307
GPL339
WT_PLACEBO_12hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23308
GPL339
WT_RAD001_48hours_2 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23309
GPL339
WT_RAD001_48hours_3 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23310
GPL339
WT_RAD001_48hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23311
GPL339
WT_RAD001_48hours_5 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23312
GPL339
WT_RAD001_12hours_4 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23313
GPL339
WT_RAD001_12hours_5 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
GSM23314
GPL339
WT_RAD001_12hours_6 Murine prostate Murine prostates were isolated from transgenic mice (probasin driven AKT) v. littermate wild-type controls treated with either RAD001 (MTOR inhibition) or placebo. 10 micrograms of total RNA was used to synthesize biotin-labeled cRNA using our standard protocol Keywords = Prostate AKT RAD001 MTOR Lot batch = 2
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes